Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel



Status:Completed
Conditions:Chronic Pain, Neurology
Therapuetic Areas:Musculoskeletal, Neurology
Healthy:No
Age Range:18 - Any
Updated:4/17/2018
Start Date:January 2012
End Date:April 2016

Use our guide to learn which trials are right for you!

RC11C3, Pilot Placebo-controlled Evaluation of Pregabalin as a Means to Prevent the Paclitaxel-Associated Acute Pain Syndrome

This randomized pilot clinical trial studies pregabalin in preventing acute pain syndrome in
patients receiving paclitaxel. Pregabalin may control the pain caused by cancer treatment.

PRIMARY OBJECTIVES: I. To obtain pilot data regarding the possible effect of pregabalin on
pain related to paclitaxel-associated acute pain syndrome (P-APS). SECONDARY OBJECTIVES: I.
To obtain pilot data regarding the possible effect of pregabalin on paclitaxel-induced
peripheral neuropathy. II. To obtain pilot data regarding the possible relative toxicities
related to pregabalin therapy in this study situation. TERTIARY OBJECTIVES: I. To
characterize neurological testing abnormalities that might occur with the P-APS, and to
evaluate neurological testing abnormalities during the period of the longer-term
chemotherapy-induced peripheral neuropathy (CIPN). II. To determine the PRO incidence and
characteristics of, and change in, P-APS and paclitaxel induced more chronic CIPN over
several cycles. These data will serve to confirm the results obtained in our previous natural
history study N08C1. OUTLINE: Patients are randomized to 1 of 2 treatment arms. ARM I:
Patients receive pregabalin orally (PO) twice daily (BID), beginning on the first night of
chemotherapy, for 12 weeks and then once daily (QD) for 1 week. ARM II: Patients receive
placebo PO BID, beginning on the first night of chemotherapy, for 12 weeks and then QD for 1
week. After completion of study treatment, patients are followed up every 30 days for 6
months.

Inclusion Criteria:

- Age > or equal to 18 years

- Ability to complete questionnaires by themselves or with assistance Paclitaxel at a
dose of 80 mg/m^2 given, in the adjuvant setting, every week for a planned course of
12 weeks without any other concurrent therapy

- Paclitaxel at a dose of 80 mg/m2 given, in the adjuvant (postoperative or
neo-adjuvant) setting, every week for a planned course of 12 weeks without any other
concurrent cytotoxic chemotherapy (trastuzumab and/or other antibody and/or small
molecule treatment is allowed, except for PARP inhibitors).

- Life expectancy > 6 months

- Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1

- Negative pregnancy test (serum or urine) done =< 7 days prior to registration, for
women of childbearing potential only (per clinician discretion)

Exclusion Criteria:

- Pregnant women

- Nursing women

- Men or women of childbearing potential who are unwilling to employ adequate
contraception since this study involves agents that have known genotoxic, mutagenic
and teratogenic effects

- Previous diagnosis of diabetic or other peripheral neuropathy

- Current, planned or previous use, within last 6 months, of gabapentin or pregabalin

- History of allergic or other adverse reactions to gabapentin or pregabalin

- Significant renal insufficiency with a history of a creatinine clearance (CrCL) <
30ml/min

- Prior exposure to neurotoxic chemotherapy

- Seizure history

- Diagnosis of fibromyalgia

- Previous exposure to paclitaxel
We found this trial at
6
sites
1000 N Oak Ave
Marshfield, Wisconsin 54449
(715) 387-5511
Marshfield Clinic - Marshfield Center The Clinic was incorporated under Wisconsin law in 1916 and...
?
mi
from
Marshfield, WI
Click here to add this to my saved trials
Duluth, Minnesota 55805
?
mi
from
Duluth, MN
Click here to add this to my saved trials
Omaha, Nebraska 68106
?
mi
from
Omaha, NE
Click here to add this to my saved trials
Rochester, Minnesota 55905
?
mi
from
Rochester, MN
Click here to add this to my saved trials
Saint Cloud, Minnesota 56303
?
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
818 N. Emporia, #403
Wichita, Kansas 67214
(316) 262-4467
Cancer Center of Kansas The physicians of Cancer Center are hematologists and oncologists. The staff...
?
mi
from
Wichita, KS
Click here to add this to my saved trials